BiomX (PHGE-WT) Stock Analysis

What BiomX does

BiomX Inc., formerly known as Chardan Healthcare Acquisition Corp., operates as a microbiome-focused enterprise. Its primary mission is the creation of both naturally occurring and genetically modified phage treatments. These therapies are designed to specifically target and eradicate bacteria implicated in skin conditions, such as those contributing to acne, as well as harmful bacterial strains associated with chronic illnesses like inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC), and various cancers. The company's approach involves identifying and confirming specific bacterial targets, then custom-designing phage compositions to combat them. Their current development portfolio comprises BX001, an investigational product aimed at enhancing the appearance of blemish-prone skin; BX002, a specialized phage blend engineered to eliminate bacteria linked to the onset of IBD; and BX003, another tailored phage cocktail developed to address particular strains of Klebsiella pneumoniae (Kp).

Key metrics

ETFs linked to PHGE-WT

Broad-market and Healthcare sector ETFs an investor holding BiomX is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PHGE-WT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for BiomX?

BiomX trades under the ticker PHGE-WT on AMEX.

Which exchange is PHGE-WT listed on?

PHGE-WT is listed on AMEX.

What sector does BiomX operate in?

BiomX is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PHGE-WT in a portfolio?

PortView shows PHGE-WT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.